Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Cash from Operations: 2019-2024

Historic Cash from Operations for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to -$57.8 million.

  • Agilon Health's Cash from Operations fell 13567.44% to -$18.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$117.2 million, marking a year-over-year increase of 390.17%. This contributed to the annual value of -$57.8 million for FY2024, which is 6301.06% up from last year.
  • According to the latest figures from FY2024, Agilon Health's Cash from Operations is -$57.8 million, which was up 6301.06% from -$156.2 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Cash from Operations registered a high of -$53.2 million during FY2020, and its lowest value of -$156.2 million during FY2023.
  • Moreover, its 5-year median value for Cash from Operations was -$130.8 million (2022), whereas its average is -$109.2 million.
  • As far as peak fluctuations go, Agilon Health's Cash from Operations tumbled by 17847.34% in 2021, and later soared by 6301.06% in 2024.
  • Agilon Health's Cash from Operations (Annual) stood at -$53.2 million in 2020, then tumbled by 178.47% to -$148.2 million in 2021, then grew by 11.71% to -$130.8 million in 2022, then fell by 19.41% to -$156.2 million in 2023, then skyrocketed by 63.01% to -$57.8 million in 2024.
  • Its last three reported values are -$57.8 million in FY2024, -$156.2 million for FY2023, and -$130.8 million during FY2022.